These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20579323)

  • 1. Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs.
    Rassnick KM; Al-Sarraf R; Bailey DB; Chretin JD; Phillips B; Zwhalen CH
    Vet Comp Oncol; 2010 Jun; 8(2):103-11. PubMed ID: 20579323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.
    Rassnick KM; Bailey DB; Russell DS; Flory AB; Kiselow MA; Intile JL; Malone EK; Balkman CE; Barnard SM
    Vet Comp Oncol; 2010 Jun; 8(2):138-52. PubMed ID: 20579327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
    Taylor F; Gear R; Hoather T; Dobson J
    J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision.
    London CA; Malpas PB; Wood-Follis SL; Boucher JF; Rusk AW; Rosenberg MP; Henry CJ; Mitchener KL; Klein MK; Hintermeister JG; Bergman PJ; Couto GC; Mauldin GN; Michels GM
    Clin Cancer Res; 2009 Jun; 15(11):3856-65. PubMed ID: 19470739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual dermatological toxicity of hydroxyurea in two dogs with spontaneously occurring tumours.
    Marconato L; Bonfanti U; Fileccia I
    J Small Anim Pract; 2007 Sep; 48(9):514-7. PubMed ID: 17617162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrochemotherapy compared to surgery for treatment of canine mast cell tumours.
    Kodre V; Cemazar M; Pecar J; Sersa G; Cor A; Tozon N
    In Vivo; 2009; 23(1):55-62. PubMed ID: 19368125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
    Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
    J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma.
    Witzig TE; Wiernik PH; Moore T; Reeder C; Cole C; Justice G; Kaplan H; Voralia M; Pietronigro D; Takeshita K; Ervin-Haynes A; Zeldis JB; Vose JM
    J Clin Oncol; 2009 Nov; 27(32):5404-9. PubMed ID: 19805688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-escalating vinblastine for the treatment of canine mast cell tumour.
    Vickery KR; Wilson H; Vail DM; Thamm DH
    Vet Comp Oncol; 2008 Jun; 6(2):111-9. PubMed ID: 19178670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
    Stanclift RM; Gilson SD
    J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.
    Habermann TM; Lossos IS; Justice G; Vose JM; Wiernik PH; McBride K; Wride K; Ervin-Haynes A; Takeshita K; Pietronigro D; Zeldis JB; Tuscano JM
    Br J Haematol; 2009 May; 145(3):344-9. PubMed ID: 19245430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer.
    Frimberger AE; Moore AS; Cincotta L; Cotter SM; Foley JW
    Clin Cancer Res; 1998 Sep; 4(9):2207-18. PubMed ID: 9748141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days.
    Wolff I; Bench K; Beijnen JH; Bruntsch U; Cavalli F; de Jong J; Groot Y; van Tellingen O; Wanders J; Sessa C
    Clin Cancer Res; 1996 Oct; 2(10):1717-23. PubMed ID: 9816122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cyclooxygenase-2 expression in canine mast cell tumours.
    Prada J; Queiroga FL; Gregório H; Pires I
    J Comp Pathol; 2012 Jul; 147(1):31-6. PubMed ID: 22079567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse haematological effects of vinblastine, prednisolone and cimetidine treatment: a retrospective study in fourteen dogs with mast cell tumours.
    Trumel C; Bourgès-Abella N; Touron C; Lanore D; Geffré A; Diquelou A; Guelfi JF; Braun JP
    J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):275-9. PubMed ID: 16050908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors.
    Spugnini EP; Vincenzi B; Baldi F; Citro G; Baldi A
    Anticancer Res; 2006; 26(6B):4585-9. PubMed ID: 17201181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of intralesional triamcinolone administration for treatment of mast cell tumors in dogs: 23 cases (2005-2011).
    Case A; Burgess K
    J Am Vet Med Assoc; 2018 Jan; 252(1):84-91. PubMed ID: 29244608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and safety of a water-soluble micellar paclitaxel (Paccal Vet) in canine mastocytomas.
    Rivera P; Akerlund-Denneberg N; Bergvall K; Kessler M; Rowe A; Willmann M; Persson G; Kastengren Fröberg G; Westberg S; von Euler H
    J Small Anim Pract; 2013 Jan; 54(1):20-7. PubMed ID: 23190121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel immunomodulator composed of human chorionic gonadotropin and bacillus Calmette-Guerin for treatment of canine mast cell tumors in clinically affected dogs.
    Henry CJ; Downing S; Rosenthal RC; Klein MK; Meleo K; Villamil JA; Fineman LS; McCaw DL; Higginbotham ML; McMichael J
    Am J Vet Res; 2007 Nov; 68(11):1246-51. PubMed ID: 17975981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.